Now Reading
Life-Changing Therapy Now Available For Stroke and Spinal Cord Injury Patients As MyndTec Launches MyndMove™

MyndTec, an award-winning, Canadian medical technology company announced today the launch of its first commercial product, a revolutionary, new therapy for the treatment of arm and hand paralysis caused by stroke or spinal cord injury. MyndMove™ therapy is based on advanced non-invasive functional electrical stimulation and uses electrical stimulation to create new neural pathways for the recovery of voluntary function following injury to the brain or spinal cord.

Over the coming week, MyndTec will unveil MyndMove at two rehabilitation conferences in Toronto, the National Spinal Cord Injury Conference (Oct 3–4) and the American Congress of Rehabilitation Medicine (Oct 8-10).

“This is truly a landmark moment in the evolution of FES therapy,” said MyndTec Founder Dr. Milos R. Popovic.  “Multiple clinical studies have demonstrated the safety and efficacy of FES therapy for the treatment of paralysis and we can now offer this life-changing therapy to patients that might benefit”.

“What makes MyndMove therapy so exciting is that the recovery of arm and hand function means that patients become more independent in performing routine activities of daily living such as eating, grooming, dressing and bathing,” said Diana Pliura, CEO of MyndTec.  “With increased independence, patients gain dignity and the burden on families and our healthcare system is decreased.”


Leave a Response